CoChat

Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention

Bates, David W. · 1995 · JAMA

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Objectives. —To assess incidence and preventability of adverse drug events (ADEs) and potential ADEs. To analyze preventable events to develop prevention strategies. Design. —Prospective cohort study. Participants. —All 4031 adult admissions to a stratified random sample of 11 medical and surgical units in two tertiary care hospitals over a 6-month period. Units included two medical and three surgical intensive care units and four medical and two surgical general care units. Main Outcome Measures. —Adverse drug events and potential ADEs. Methods. —Incidents were detected by stimulated self-report by nurses and pharmacists and by daily review of all charts by nurse investigators. Incidents were subsequently classified by two independent reviewers as to whether they represented ADEs or potential ADEs and as to severity and preventability. Results. —Over 6 months, 247 ADEs and 194 potential ADEs were identified. Extrapolated event rates were 6.5 ADEs and 5.5 potential ADEs per 100 nonobstetrical admissions, for mean numbers per hospital per year of approximately 1900 ADEs and 1600 potential ADEs. Of all ADEs, 1% were fatal (none preventable), 12% life-threatening, 30% serious, and 57% significant. Twenty-eight percent were judged preventable. Of the life-threatening and serious ADEs, 42% were preventable, compared with 18% of significant ADEs. Errors resulting in preventable ADEs occurred most often at the stages of ordering (56%) and administration (34%); transcription (6%) and dispensing errors (4%) were less common. Errors were much more likely to be intercepted if the error occurred earlier in the process: 48% at the ordering stage vs 0% at the administration stage. Conclusion. —Adverse drug events were common and often preventable; serious ADEs were more likely to be preventable. Most resulted from errors at the ordering stage, but many also occurred at the administration stage. Prevention strategies should target both stages of the drug delivery process. (JAMA. 1995;274:29-34)

Overview

Integrity signals

Registry

Crossref · 10.1001/jama.1995.03530010043033

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

The publisher hasn’t deposited this paper’s reference list.

Metadata

Authors
Bates, D. W.
Corresponding author
Bates, David W.
Venue
JAMA
Published
1995-07-05
Volume
274
Issue
1
Pages
29
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W4292550096
Cited by
2,127
References
0
Citations by year
2026: 39 · 2025: 52 · 2024: 47 · 2023: 51 · 2022: 68 · 2021: 74 · 2020: 68 · 2019: 70 · 2018: 84 · 2017: 84 · 2016: 93 · 2015: 77 · 2014: 84 · 2013: 99 · 2012: 129
FWCI
39.09
Type
journal article
Language
en
Open access
closed
Locations
  • JAMA (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
Funders
Agency for Healthcare Research and Quality (R01-HS07107-01)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
adverse drug reactions, preventability, medication errors, hospitalization, error prevention strategies, medication administration errors, patient safety, intensive care unit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention. https://app.cochat.ai/papers/10.1001/jama.1995.03530010043033
The paper
Bates, D. W. (1995). Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention. JAMA. https://doi.org/10.1001/jama.1995.03530010043033

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.